With respect to colorectal cancer (CRC), the effects of anti-TNFα mAb on tumors have been evaluated in vitro, in inflammatory carcinogenesis models, and in CRC subcutaneous allogeneic transplant models. The gene discussed is TNF; the disease is colorectal cancer.